COVID and Coagulation » COVID and Coagulation, Clinical

Abstract Number: PB0177

COVID-19 Vaccination and Anticoagulation: Potential Effects on Anticoagulation Control in Patients Using Vitamin K Antagonists

C. Visser¹, J.S. Biedermann¹, M.C. Nierman², F.J.M. van der Meer³, S.C. Cannegieter^3,4, W.M. Lijfering⁴, M.J.H.A. Kruip¹

Abstract Number: PB0165

COVID-19-Related Thrombosis in Japan: Results of a Questionnaire-based Survey in 2020

H. Horiuchi¹, E. Morishita², T. Urano³, K. Yokoyama⁴, - The Questionnaire-Survey Joint Team on the COVID-19-Related Thrombosis^5,6,7

Abstract Number: PB0255

Cross-talk between the Inflammatory Response and Coagulopathy: Single-center Report

Y.B. Tor¹, S. Kalayoglu Besisik², M. Ozbalak², M. Kose¹, A. Medetalibeyoglu¹, N. Senkal¹, A. Cagatay³, S. Simsek Yavuz³, A. Gul⁴, M. Erelel⁵, F. Esen⁶, T. Tukek¹

Abstract Number: PO126

D Dimer and other Biomarkers in Dengue Patients within a Doble Viral Circulation Scenery (Dengue/COVID-19)

F. Chuliber¹, R. vanden Ryn², N. Schutz^1,3, L. Barrera^2,3, M.S. López^2,3, C. Raff², V. Privitera¹, D. Mezzarobba¹, M. Villagra Iturre¹, V. Estela S^1,3, D. Penchasky^1,3, G. Jimenez^2,3, M. Rolan², D. Arrigo^2,3, J. Arbelbide^1,3, F. Seoane², M. Martinuzzo^2,3

Abstract Number: PB0221

D-dimer as a Predictive Marker for Mortality in Hospitalized COVID-19 Patients

S. Hassan^1,2, B. Ferrari³, R. Rossio⁴, V. la Mura⁵, A. Artoni⁵, F. R. Rosendaal², R. Gualtierotti^1,3, I. Martinelli³, F. Peyvandi^1,3, COVID-19 hospital network

Abstract Number: LPB0058

D-dimer Elevation at Time of Admission Is Associated with Need for Ventilator Support among Pediatric Patients with COVID-19 Infection

N. Wilken¹, V. Kostousov^1,2, K. Bruzdoski², S. Sartain³, K. Krum^1,2, L. Hensch^1,2, J. Teruya^1,2, S.-K.R. Hui^1,2

Abstract Number: PB0258

D-dimer Increase during Hospitalization is Associated with Negative Outcomes in Patients with COVID-19 Infection

E. Panchenko¹, E. Kropacheva¹, A. Komarov¹, A. Suvorov¹, F. Paveev¹, N. Pogosova¹, S. Boytson¹

Abstract Number: PB0306

Ddimer and the Correlation with the Mortality Rate in Covid Patients: A Single Centre Report in Medan Indonesia

S.S. Widjaja¹, L. Mutiara², S. Tan², F. Fenny²

Abstract Number: OC 50.1

Development of an Artificial Intelligence Model to Predict Venous Thromboembolic Disease in COVID-19 Patients at Hospital Admission

M.S. Marcolino¹, W.C. Silveira¹, B.B.M. Paiva¹, C. Valiense¹, M.A. Gonçalves¹, S.M. Rezende¹, M.A.P. Martins¹, M.C. Pires¹, R.T. Silva¹, L.E.F. Ramos¹, T.L.S. Sales², M.V.R.S. Silva¹, F. Anschau³, F.A. Botoni⁴, G.P. Crestani⁵, K.P.M.P. Martins¹, R.L.R. Carvalho¹, L.M. Oliveira¹, C.A. Polanczyk⁶

Abstract Number: LPB0057

Diagnostic Management of Suspected Pulmonary Embolism in Patients with COVID-19: A Prospective Cohort Study

M.A.M. Stals¹, F.HJ Kaptein¹, RHH Bemelmans², T van Bemmel³, DCW Braeken⁴, DD Deenstra⁵, YPA van Dooren⁶, LM Faber⁷, MJJH Grootenboers⁸, LR de Haan⁹, C Haazer¹⁰, A Iglesias del Sol¹¹, S Kelliher¹², RI Meijer¹³, PE Westerweel¹⁴, FA Klok¹, MV Huisman¹, on behalf of the Dutch COVID & Thrombosis Coalition (DCTC)

Abstract Number: PB0191

Differences of Venous Thromboembolism (VTE) Events in COVID-19 and Non-COVID-19 Hospitalized Patients

M.C. Chindamo^1,2, M.B. Manhaes², L.D. Carvalho², G.G. Sardinha², A.M. Marques², H.C. Goudar², A.B. Nunes², P.R. Carmo Jr^1,2, D.R. Salgado^1,2

Abstract Number: PB0210

Do Thrombotic and Bleeding Phenotypes Differ in Patients with Severe COVID-19 Compared to Other Viral Pneumonias in the Context of Extracorporeal Membrane Oxygenation?

A. Weatherill¹, M. Gaspar², M. Passariello³, M. Laffan⁴, S. Ledot³, D.R. Arachchillage²

Abstract Number: PB0200

Does a National Lockdown Affect the Characterises of Deep Vein Thromboses and Patients in the Community?

A. Shahid¹, N. Aden², M. Howard¹, S. Narayanamoorthi¹, T. Khan¹

Abstract Number: PB0172

Does Hydroxychloroquine Prevent Symptomatic Venous Thromboembolism in Patients with Mild to Moderate COVID-19?

P.-M. Roy^1,2,3, V. Dubée^4,5, B. Vielle⁶, O. Blanchet⁷, J.-M. Lemée⁸, R. Dhersin⁴, S. Boucher^9,1, C. Belizna^10,1, G. Urbanski^11,1, O. Sanchez^12,13,3, P. Girard^14,3, A. Elias^15,3, D. Douillet^16,1,3, I. Pellier^17,5, HYCOVID Study Group

Abstract Number: PB0189

Does Thromboelastography Predict Clinical Outcomes in COVID-19?

M. Gaddam¹, A. Wahab², A. Borgert¹, S. Frankki¹, U. Perepu², S. Lentz², L. Rosenstein¹

Abstract Number: PB0222

Dynamic Monitoring of Hemostasis and Correction of Heparin Therapy Can Halve the Number of Thrombotic Complications in Patients with Severe COVID-19

F. Ataullakhanov^1,2,3,4,5, S. Shakhidzhanov¹, D. Nechipurenko^4,1,3, I. Serebrisky⁶, S. Karamzin¹, I. Spiridonov¹, D. Zateyshchikov⁷, M. Panteleev^1,3,4,5, V. Mustyatsa^3,1, D. Morozova⁸, E. Koltsova^1,3, E. Seregina^3,1, S. Ratchina⁹, A. Gubkin¹⁰, A. Martyanov^3,1, E. Grishchuk², D. Protsenko¹¹, C. Tsarenko¹², H. Vasilieva¹³, A. Rumyantsev³

Abstract Number: PB0231

Effect of Dexamethasone on Direct Oral Anticoagulant Plasma Levels in Patients with COVID-19

F. Bosch^1,2, M. Candeloro³, N. Potere³, E. Porreca³, M. Di Nisio³, P.W. Kamphuisen^1,2

Abstract Number: PB0207

Effects of Dalteparin on Anti-Xa Levels Cannot Be Predicted in Critically Ill COVID-19 Patients

C. van der Heijden¹, E. Kooistra¹, R. ter Heine¹, R. Brüggemann¹, J. Walburgh Schmidt¹, E. de Grouw¹, T. Frenzel¹, P. Pickkers¹, J. Leentjens¹

Abstract Number: PB0241

Efficiency of Anticoagulant Protein C System in Patients with Coronavirus Infection Caused by the SARS-CoV-2

O. Matvienko¹, N. Korsakova¹, A. Lerner², T. Shvedova², L. Papayan¹, O. Golovina¹

Abstract Number: OC 70.3

Endothelial Targeting in the Treatment of Early Clinical Stages of COVID-19: Results of a Randomized Placebo-controlled Trial

A. Gonzalez Ochoa¹, J. Raffetto², A.G Hernandez Ibarra³